References
- Wang JD, Xie J, Zhou XJ, et al. Ferritin enhances SPIO tracking of C6 Rat Glioma Cells by MRI. Mol Imaging Biol. 2011;13:87–93.
- Fazilati M. Folate decorated magnetite nanoparticles: synthesis and targeted therapy against ovarian cancer. Cell Biol Int. 2014;38:154–163.
- Wen S, Liu DF, Cui Y, et al. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles. Nanomedicine. 2014;10:639–649.
- Comes FM, Baldi G, Bonacchi D, et al. Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer. Small. 2010;6:366–370.
- Meng H, Chen JY, Mi L, et al. Conjugates of folic acids with BSA-coated quantum dots for cancer cell targeting and imaging by single-photon and two-photon excitation. J Biol Inorg Chem. 2011;16:117–123.
- Li H, Yan K, Shang Y, et al. Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging. Acta Biomater. 2015;15:117–126.
- Guo Z, Zhang P, Song M, et al. Synthesis and preliminary evaluation of novel (99m)Tc-labeled folate derivative via click reaction for SPECT imaging. Appl Radiat Isot. 2014;91:24–30.
- Liu DF, An YL, Teng GJ, et al. Folate conjugated magnetic bovine serum albumin nanoparticles for target imaging of glioma cells. International Symposium on Signal Processing Biomedical Engineering and Informatics 2014;143–1147.
- Du YQ, Zhang DS, Liu H, et al. Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9. BMC Biotechnol. 2009;9:84.
- Li YT, Liu J, Zhong YJ, et al. Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo. Int J Nanomedicine. 2011;6:2805–2819.
- Tang QS, An YL, Liu DF, et al. Folate/NIR 797-conjugated albumin magnetic nanospheres: synthesis, characterisation, and in vitro and in vivo targeting evaluation. Plos One. 2014;9:e106483.
- Miao FQ, An YL, Rui Y, et al. Preparation of DOX/BSANP and its antitumor effect on Bel-7404 liver cancer cells in vitro and in vivo. J Biomed Mater Eng. 2014;24:599–607.
- Yang R, An YL, Miao FQ, et al. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo. Int J Nanomedicine. 2014;9:4231–4243.
- Tang QS, Chen DZ, Xue WQ, et al. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo. Int J Nanomedicine. 2011;6:3077–3085.
- Wang ZJ, Boddington S, Wendland M, et al. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr Radiol. 2008;38:529–537.
- Meier R, Henning TD, Boddington S, et al. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. Radiology. 2010;255:527–535.
- Choi H, Choi SR, Zhou R, et al. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol. 2004;11:996–1004.
- Xiong L, Yang T, Yang Y, et al. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010;31:7078–7085.
- Salvati A, Pitek AS, Monopoli MP, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8:137–143.